Physician profile
Judith A Sanders
NPI 1093948382
$498.74
in general payments reported to CMS, 2019-2025
12 companies · $39.39 in 2025
The $39.39 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $219 · 2022: $89.88 · 2023: $73.24 · 2024: $77.34 · 2025: $39.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $189.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $128.39 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $89.79 | 2022-2024 | |
| Janssen Pharmaceuticals, INC | $49.58 | 2021-2022 | |
| Lilly USA, LLC | $45.48 | 2021-2022 | |
| Pfizer INC. | $40.65 | 2023-2025 | |
| Amgen INC. | $36.45 | 2022-2025 | Repatha |
| Nevro Corp. | $27.57 | 2023 | Senza |
| Novo Nordisk INC | $21.95 | 2023 | Rybelsus, Ozempic |
| Glaxosmithkline, LLC. | $15.94 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $15.54 | 2021 | |
| Avanir Pharmaceuticals, INC. | $13.80 | 2021 | |
| Abbvie INC. | $13.60 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Judith Sanders listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.